These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12821498)

  • 21. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance in Brachyspira pilosicoli with special reference to point mutations in the 23S rRNA gene associated with macrolide and lincosamide resistance.
    Karlsson M; Fellström C; Johansson KE; Franklin A
    Microb Drug Resist; 2004; 10(3):204-8. PubMed ID: 15383163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.
    Drago L; Mattina R; Legnani D; Romano CL; Vianello E; Ricci C; De Vecchi E
    Int J Immunopathol Pharmacol; 2011; 24(4):1027-35. PubMed ID: 22230408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of viridans group streptococci.
    Tuohy M; Washington JA
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of four antimicrobial agents against North American isolates of porcine Serpulina pilosicoli.
    Duhamel GE; Kinyon JM; Mathiesen MR; Murphy DP; Walter D
    J Vet Diagn Invest; 1998 Oct; 10(4):350-6. PubMed ID: 9786523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
    Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter survey of antimicrobial susceptibility of Prevotella species as determined by Etest methodology.
    Ulger Toprak N; Veloo ACM; Urban E; Wybo I; Justesen US; Jean-Pierre H; Morris T; Akgul O; Kulekci G; Soyletir G; Nagy E;
    Anaerobe; 2018 Aug; 52():9-15. PubMed ID: 29860038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones.
    Schumacher UK; Single B
    Zentralbl Bakteriol; 1998 May; 287(4):421-5. PubMed ID: 9638871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
    Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
    Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
    Shanker S; Toohey M; Munro R
    Eur J Clin Microbiol; 1982 Oct; 1(5):298-300. PubMed ID: 6223813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon.
    Uwaydah M; Jradeh M; Shihab Z
    J Antimicrob Chemother; 1996 Aug; 38(2):283-6. PubMed ID: 8877543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Chemother; 2004 Feb; 16(1):30-7. PubMed ID: 15077996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.
    Decousser JW; Allouch PY; Courvalin P; Leclercq R;
    Int J Antimicrob Agents; 2002 Sep; 20(3):186-95. PubMed ID: 12385697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
    Betriu C; Redondo M; Palau ML; Sánchez A; Gómez M; Culebras E; Boloix A; Picazo JJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1838-41. PubMed ID: 10858339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
    Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses.
    Sobottka I; Cachovan G; Stürenburg E; Ahlers MO; Laufs R; Platzer U; Mack D
    Antimicrob Agents Chemother; 2002 Dec; 46(12):4019-21. PubMed ID: 12435716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.